Boston Scientific (BSX) reported $4.12 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 14.5%. EPS of $0.62 for the same period compares to $0.53 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $4.02 billion, representing a surprise of +2.51%. The company delivered an EPS surprise of +6.90%, with the consensus EPS estimate being $0.58.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...